PE20090757A1 - Formulaciones que contienen triazinonas y hierro - Google Patents

Formulaciones que contienen triazinonas y hierro

Info

Publication number
PE20090757A1
PE20090757A1 PE2008000901A PE2008000901A PE20090757A1 PE 20090757 A1 PE20090757 A1 PE 20090757A1 PE 2008000901 A PE2008000901 A PE 2008000901A PE 2008000901 A PE2008000901 A PE 2008000901A PE 20090757 A1 PE20090757 A1 PE 20090757A1
Authority
PE
Peru
Prior art keywords
iron
formulations containing
triazinones
amount
carboxyl acid
Prior art date
Application number
PE2008000901A
Other languages
English (en)
Inventor
Stefan Hofmann
Iris Heep
Hans-Christian Mundt
Islas Juan Agustin Torres
Original Assignee
Bayer Animal Health Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39787877&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20090757(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Animal Health Gmbh filed Critical Bayer Animal Health Gmbh
Publication of PE20090757A1 publication Critical patent/PE20090757A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/295—Iron group metal compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Obesity (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

REFERIDO A UNA FORMULACION QUE COMPRENDE: A) TRIAZINONAS DE FORMULAS I, II, DONDE R1 ES R3-SO2-, R3-S-; R2 ES ALQUILO, ALCOXI, HALOGENO O SO2N(CH3)2; R3 ES HALOALQUILO; R4 Y R5 SON CADA UNO H, Cl; R6 ES F, Cl, EN UNA CANTIDAD DE 3-7% (m/V); Y B) COMPUESTOS DE HIERRO (+2) O HIERRO (+3) SELECCIONADOS DE: SALES DE ACIDO CARBOXILICO DE HIERRO (+2), COMPUESTOS COMPLEJOS DE ACIDO CARBOXILICO DE HIERRO (+3), CCOMPLEJOS DE HIERRO (III)-POLISACARIDO POLINUCLEARES, ENTRE OTROS EN UNA CANTIDAD DE 20-25% (m/V). TAMBIEN SE REFIERE A UN PROCESO DE PREPARACION. DICHO COMPUESTO TIENE ACTIVIDAD SOBRE LOS COCCIDIOS Y ES UTIL EN EL TRATAMIENTO DE COCCIDIOSIS Y DEFICIENCIAS DE DE HIERRO EN ANIMALES Y PERSONAS
PE2008000901A 2007-06-01 2008-05-27 Formulaciones que contienen triazinonas y hierro PE20090757A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102007025908A DE102007025908A1 (de) 2007-06-01 2007-06-01 Formulierungen enthaltend Triazinone und Eisen

Publications (1)

Publication Number Publication Date
PE20090757A1 true PE20090757A1 (es) 2009-07-23

Family

ID=39787877

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2008000901A PE20090757A1 (es) 2007-06-01 2008-05-27 Formulaciones que contienen triazinonas y hierro

Country Status (29)

Country Link
EP (5) EP3741371A1 (es)
JP (1) JP5591692B2 (es)
KR (1) KR101517861B1 (es)
CN (1) CN101678031B (es)
AR (1) AR066780A1 (es)
BR (2) BRPI0812172B8 (es)
CA (1) CA2688613C (es)
CL (1) CL2008001533A1 (es)
CO (1) CO6241102A2 (es)
CR (1) CR11121A (es)
DE (1) DE102007025908A1 (es)
DK (1) DK3210610T3 (es)
ES (2) ES2624794T3 (es)
FR (1) FR20C1049I1 (es)
HK (1) HK1141993A1 (es)
HR (2) HRP20170719T1 (es)
HU (4) HUE049978T2 (es)
LT (1) LT3210610T (es)
MX (2) MX336910B (es)
NI (1) NI200900206A (es)
PE (1) PE20090757A1 (es)
PL (2) PL3210610T3 (es)
PT (2) PT2164496T (es)
RU (1) RU2506081C9 (es)
SI (2) SI2164496T1 (es)
TW (1) TWI417101B (es)
UA (1) UA97985C2 (es)
UY (1) UY31106A1 (es)
WO (1) WO2008145281A2 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007025908A1 (de) 2007-06-01 2008-12-04 Bayer Healthcare Ag Formulierungen enthaltend Triazinone und Eisen
SI22751A (sl) 2008-04-03 2009-10-31 Krka, D.D., Novo Mesto Toltrazuril z izboljĺ animi lastnostmi za raztapljanje
DE102009012423A1 (de) 2009-03-10 2010-09-16 Bayer Animal Health Gmbh Zubereitung auf Ölbasis
KR101242535B1 (ko) * 2010-10-05 2013-03-12 주식회사이-글벳 콕시듐 치료 및 예방을 위한 조성물의 제조방법
CN102250261B (zh) * 2010-12-07 2013-02-20 天津怀仁制药有限公司 生产右旋糖酐铁的方法
CN102772363B (zh) * 2012-08-22 2013-10-09 青岛康地恩药业股份有限公司 一种含泊那珠利的溶液剂及其制备方法
EP2740492A1 (en) * 2012-12-07 2014-06-11 Ceva Sante Animale Triazine formulations with a second active ingredient and surfactant(s)
EP2740469A1 (en) * 2012-12-07 2014-06-11 Ceva Sante Animale New treatments with triazines
EP2740470A1 (en) * 2012-12-07 2014-06-11 Ceva Sante Animale Treatment of Coccidiosis with intramuscular triazine composition
EP3020284B1 (en) * 2014-11-03 2018-09-12 Lipidos Toledo S.A. Supplementary feed for oral administration for reducing neonatal mortality of piglets
CN108472351A (zh) 2015-12-29 2018-08-31 英特维特国际股份有限公司 球虫病疫苗
KR20210009332A (ko) * 2018-05-16 2021-01-26 세바 상뜨 아니말르 수의학적 조성물 및 이의 비-인간 포유동물에서 철 결핍을 조절하기 위한 용도
EP3578182A1 (en) 2018-06-05 2019-12-11 Bayer Animal Health GmbH Formulations containing triazinones and iron with a low amount of free iron ions
EP3578181A1 (en) * 2018-06-05 2019-12-11 Bayer Animal Health GmbH Formulation for use in the simultaneous treatment of coccidial infections and iron deficiencies
CN109430556A (zh) * 2018-11-26 2019-03-08 江西新世纪民星动物保健品有限公司 一种包含托曲珠利和铁的制剂

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1183940A (en) 1966-10-22 1970-03-11 Fisons Pharmaceuticals Ltd Ferric Hydroxide Complexes
DE2413722C3 (de) 1974-03-21 1982-04-08 Bayer Ag, 5090 Leverkusen Neue 1-(4-Phenoxy-phenyl)-1,3,5-triazin-Derivate, ein Verfahren zu ihrer Herstellung sowie ihre Anwendung als Arzneimittel
DE2718799A1 (de) 1977-04-27 1978-11-09 Bayer Ag 1-(4-phenoxy-phenyl)-1,3,5-triazin- derivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel und wachstumsfoerderer
DE3300793A1 (de) 1983-01-12 1984-07-12 Bayer Ag, 5090 Leverkusen Coccidiosemittel
EP0634174A1 (en) 1993-07-13 1995-01-18 Takeda Chemical Industries, Ltd. Antianemic composition for veterinary use
JPH0776524A (ja) * 1993-07-13 1995-03-20 Takeda Chem Ind Ltd 動物用抗貧血剤
DE19519821A1 (de) 1995-05-31 1996-12-05 Bayer Ag Mittel gegen parasitäre Protozoen
DE19603984A1 (de) 1996-02-05 1997-08-07 Bayer Ag Granulate von Triazinen
US5883095A (en) * 1997-08-07 1999-03-16 University Of Kentucky Research Foundation Formulations and methods to treat and prevent equine protozoal myeloencephalitis
DE19824483A1 (de) * 1998-06-02 1999-12-09 Bayer Ag Halbfeste wäßrige Zubereitungen für orale Applikation von Toltrazuril-Sulfon
CA2346463A1 (en) * 1998-10-08 2000-04-13 New Ace Research Company Use of sodium salts of triazine anticoccidial agents for the prevention and treatment of protozoal disease
US6150361A (en) 1998-12-22 2000-11-21 Bayer Corporation Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma
AU2198100A (en) * 1998-12-22 2000-07-12 Bayer Corporation Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma
US6194408B1 (en) * 1998-12-22 2001-02-27 Bayer Corporation Triazineone compounds for treating diseases due to Sarcocystis, Neospora and Toxoplasma
DE19958388A1 (de) 1999-12-03 2001-06-07 Bayer Ag Triazinonverbindungen zur Behandlung von durch den Befall mit parasitischen Protozoen bedingten Krankheiten
DE10040174A1 (de) * 2000-08-17 2002-02-28 Bayer Ag Verwendung von Triazintrion-Sulfonen zur Bekämpfung von Coccidiosen
DE10049468A1 (de) 2000-10-06 2002-04-11 Bayer Ag N-Alkoxyalkyl-substituierte Benzimidazole, ihre Herstellung und ihre Verwendung als Mittel gegen parasitäre Protozoen
DE102004042958A1 (de) * 2004-09-02 2006-03-09 Bayer Healthcare Ag Neue antiparasitäre Kombination von Wirkstoffen
CN100453083C (zh) * 2005-11-19 2009-01-21 江西华太药业有限公司 右旋糖酐铁分散片
CN1839845A (zh) * 2006-01-24 2006-10-04 苏州科牧动物药品有限公司 含有妥曲珠利的抗球虫溶液及其制备方法
DE102006038292A1 (de) 2006-08-16 2008-02-21 Bayer Healthcare Ag Transdermale Anwendung von Triazinen zur Bekämpfung von Coccidien-Infektionen
DE102007025908A1 (de) 2007-06-01 2008-12-04 Bayer Healthcare Ag Formulierungen enthaltend Triazinone und Eisen
EP2740470A1 (en) 2012-12-07 2014-06-11 Ceva Sante Animale Treatment of Coccidiosis with intramuscular triazine composition
EP2740469A1 (en) 2012-12-07 2014-06-11 Ceva Sante Animale New treatments with triazines

Also Published As

Publication number Publication date
TW200914025A (en) 2009-04-01
BRPI0812172B8 (pt) 2021-05-25
EP3210610B1 (de) 2020-04-22
AR066780A1 (es) 2009-09-09
PL2164496T3 (pl) 2017-08-31
CN101678031A (zh) 2010-03-24
UA97985C2 (ru) 2012-04-10
HUE049978T2 (hu) 2020-11-30
MX351332B (es) 2017-10-11
UY31106A1 (es) 2009-01-05
DE102007025908A1 (de) 2008-12-04
HUS1900046I1 (hu) 2019-11-28
HRP20170719T1 (hr) 2017-07-28
BR122019020753B1 (pt) 2020-06-09
RU2506081C9 (ru) 2014-09-27
PL2164496T4 (pl) 2019-12-31
NI200900206A (es) 2011-08-10
SI2164496T1 (sl) 2017-06-30
JP2010528996A (ja) 2010-08-26
TWI417101B (zh) 2013-12-01
CA2688613C (en) 2017-02-21
RU2506081C2 (ru) 2014-02-10
DK3210610T3 (da) 2020-05-18
CO6241102A2 (es) 2011-01-20
EP3741371A1 (de) 2020-11-25
WO2008145281A8 (de) 2009-11-26
WO2008145281A2 (de) 2008-12-04
FR20C1049I1 (fr) 2020-11-27
SI3210610T1 (sl) 2020-07-31
LT3210610T (lt) 2020-05-25
PT2164496T (pt) 2017-05-22
EP3210610A1 (de) 2017-08-30
HRP20200777T1 (hr) 2020-07-24
KR20110022510A (ko) 2011-03-07
MX2009012406A (es) 2009-12-09
ES2789775T3 (es) 2020-10-26
CR11121A (es) 2010-04-06
ES2624794T3 (es) 2017-07-17
RU2009148585A (ru) 2011-07-20
BRPI0812172A2 (pt) 2014-12-02
MX336910B (es) 2016-02-02
KR101517861B1 (ko) 2015-05-18
PT3210610T (pt) 2020-05-18
CA2688613A1 (en) 2008-12-04
PL3210610T3 (pl) 2020-07-27
EP2164496B1 (de) 2017-04-12
BR122019020753B8 (pt) 2021-07-27
CN101678031B (zh) 2013-06-12
BRPI0812172B1 (pt) 2020-03-03
JP5591692B2 (ja) 2014-09-17
HUE031907T2 (en) 2017-08-28
HUS2000041I1 (hu) 2020-11-30
EP3692993A1 (de) 2020-08-12
EP2164496A2 (de) 2010-03-24
WO2008145281A3 (de) 2009-08-13
HK1141993A1 (en) 2010-11-26
EP3711766A1 (de) 2020-09-23
CL2008001533A1 (es) 2008-12-05

Similar Documents

Publication Publication Date Title
PE20090757A1 (es) Formulaciones que contienen triazinonas y hierro
AR072224A1 (es) Derivados de pirimidona sustituidos
PE20160682A1 (es) Composiciones y metodos para modular los receptores x farnesoides
PE20142294A1 (es) Compuestos de indol e indazol que activan la ampk
ATE376833T1 (de) Chinazolinon-derivate als vanilloid-antagonisten
RS52119B (en) 4-phenylamino-HINAZOLIN-6-IL-STARCHES
CO6280528A2 (es) Compuesto de acido carboxilico
ES2330313T3 (es) Derivados de tiofeno como agentes antivirales contra infeccion por flavivirus.
CY1119220T1 (el) Μονοκυκλικο παραγωγο πυριδινης
MA38540A1 (fr) Dérivés de naphtyridine utiles comme antagonistes de l'intégrine alpha-v-bêta-6
AR054799A1 (es) Derivados de oxindol
ATE537830T1 (de) Nicotinamid derivate und ihre verwendung als therapeutika
MA37891B1 (fr) Alcoxypyrazoles comme activateurs de guanylate cyclase soluble
DE602005008953D1 (de) Substituierte chinolinderivate als inhibitoren von mitotischem kinesin
PE20050664A1 (es) Derivados de 1h-imidazo[4,5-c]quinolina
PE20060298A1 (es) Derivados de acido carboxilico de bencimidazolona
PE20071322A1 (es) Derivados de 2-morfolinopirimidina como inhibidores de fosfatidinoinositol(pi) 3-quinasa
AR072962A1 (es) Derivados de pirimidin-4-ona sustituidos
PE20091818A1 (es) DERIVADOS POLISUSTITUIDOS DE 2-ARIL-6-FENIL-IMIDAZO[1,2-a] PIRIDINAS, SU PREPARACION Y SU APLICACION EN TERAPEUTICA
AR063988A1 (es) Derivados heterociclicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen
PE20050145A1 (es) Dihidroquinazolinas sustituidas como agentes antivirales
AR061520A1 (es) Derivados de cinamoil-piperazina
MX2008013728A (es) Inductor de neurogenesis o agente terapeutico de neuropatia que abarca el derivado del eter alkilico o sal del mismo.
PE20142282A1 (es) Nuevos derivados de aril-quinolina
AR078536A1 (es) Derivados de pirazol como ligandos del receptor de estrogeno

Legal Events

Date Code Title Description
FG Grant, registration